» Articles » PMID: 17016435

Krüppel-like Factor 4 Exhibits Antiapoptotic Activity Following Gamma-radiation-induced DNA Damage

Overview
Journal Oncogene
Date 2006 Oct 4
PMID 17016435
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

In response to gamma-radiation-induced DNA damage, organisms either activate cell cycle checkpoint and repair machinery or undergo apoptosis to eliminate damaged cells. Although previous studies indicated that the tumor suppressor p53 is critically involved in mediating both responses, how a cell decides which pathway to take is not well established. The zinc-finger-containing transcription factor, Krüppel-like factor 4 (KLF4), is a crucial mediator for the checkpoint functions of p53 after gamma-irradiation and does so by inhibiting the transition from the G(1) to S and G(2) to M phases of the cell cycle. Here, we determined the role of KLF4 in modulating the apoptotic response following gamma-irradiation. In three independent cell systems including colorectal cancer cells and mouse embryo fibroblasts in which expression of KLF4 could be manipulated, we observed that gamma-irradiated cells underwent apoptosis if KLF4 was absent. In the presence of KLF4, the degree of apoptosis was significantly reduced and cells resorted to checkpoint arrest. The mechanism by which KLF4 accomplished this antiapoptotic effect is by activating expression of the cell cycle arrest gene, p21(WAF1/CIP1), and by inhibiting the ability of p53 to transactivate expression of the proapoptotic gene, BAX. Results of our study illustrate an unexpected antiapoptotic function of KLF4, heretofore considered a tumor suppressor in colorectal cancer, and suggest that KLF4 may be an important determinant of cell fate following gamma-radiation-induced DNA damage.

Citing Articles

USP11 promotes renal tubular cell pyroptosis and fibrosis in UUO mice via inhibiting KLF4 ubiquitin degradation.

Wang X, Xie X, Ni J, Li J, Sun X, Xie H Acta Pharmacol Sin. 2024; 46(1):159-170.

PMID: 39147900 PMC: 11696738. DOI: 10.1038/s41401-024-01363-z.


Enhanced infection efficiency and cytotoxicity mediated by vpx-containing lentivirus in chimeric antigen receptor macrophage (CAR-M).

Gao Y, Ju Y, Ren X, Zhang L, Yin X Heliyon. 2023; 9(12):e21886.

PMID: 38058430 PMC: 10696197. DOI: 10.1016/j.heliyon.2023.e21886.


Identification of genetic associations and functional SNPs of bovine KLF6 gene on milk production traits in Chinese holstein.

Liu Y, Han B, Zheng W, Peng P, Yang C, Jiang G BMC Genom Data. 2023; 24(1):72.

PMID: 38017423 PMC: 10685595. DOI: 10.1186/s12863-023-01175-w.


Therapeutic Targeting of Krüppel-Like Factor 4 and Its Pharmacological Potential in Parkinson's Disease: a Comprehensive Review.

Zamanian M, Golmohammadi M, Amin R, Bustani G, Romero-Parra R, Zabibah R Mol Neurobiol. 2023; 61(6):3596-3606.

PMID: 37996730 PMC: 11087351. DOI: 10.1007/s12035-023-03800-2.


protects thymus integrity during late pregnancy.

Depoers L, Dumont-Lagace M, Quoc-Huy Trinh V, Houques C, Cote C, Larouche J Front Immunol. 2023; 14:1016378.

PMID: 37180153 PMC: 10174329. DOI: 10.3389/fimmu.2023.1016378.


References
1.
Eberspaecher H, Seldin M, de Crombrugghe B . A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J Biol Chem. 1996; 271(49):31384-90. DOI: 10.1074/jbc.271.49.31384. View

2.
Shields J, Yang V . Two potent nuclear localization signals in the gut-enriched Krüppel-like factor define a subfamily of closely related Krüppel proteins. J Biol Chem. 1997; 272(29):18504-7. PMC: 2268085. DOI: 10.1074/jbc.272.29.18504. View

3.
Waldman T, Zhang Y, Dillehay L, Yu J, Kinzler K, Vogelstein B . Cell-cycle arrest versus cell death in cancer therapy. Nat Med. 1997; 3(9):1034-6. DOI: 10.1038/nm0997-1034. View

4.
Zhang W, Shields J, Sogawa K, Fujii-Kuriyama Y, Yang V . The gut-enriched Krüppel-like factor suppresses the activity of the CYP1A1 promoter in an Sp1-dependent fashion. J Biol Chem. 1998; 273(28):17917-25. PMC: 2275057. DOI: 10.1074/jbc.273.28.17917. View

5.
Hermeking H, Lengauer C, Polyak K, He T, Zhang L, Thiagalingam S . 14-3-3sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell. 1998; 1(1):3-11. DOI: 10.1016/s1097-2765(00)80002-7. View